// App-Quantinova.ai

: Clinical Efficacy of Leflunomide/Hydroxychloroquine Combination Therapy in Patients with Primary Sjogren’s Syndrome: Results of a Placebo-Controlled Double-Blind Randomized Clinical Trial

Researchers

Presenter

  • Eefje H.M. van der Heijden

Principal Investigators

  • Frederique M. Moret

  • Maarten R. Hillen

  • Ana P. Lopes

  • Toine Rosenberg

  • Nard Janssen

  • Aike A. Kruize

  • Joel A.G. van Roon

Medical Centers

  • Pediatric Surgery, University Medical Center Utrecht, Utrecht, Netherlands

  • Department of Rheumatology and Clinical Immunology and Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands

  • Department of Rheumatology and Clinical Immunology and Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands

  • Pediatric Surgery, University Medical Center Utrecht, Utrecht, Netherlands

  • Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands

  • Department of Oral and Maxillofacial Surgery, University Medical Center Utrecht, Utrecht, Netherlands

  • Pediatric Surgery, University Medical Center Utrecht, Utrecht, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • HWA-486

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved